ClinDatrix: Specialized Clinical Trials for Urology
Since 2002, ClinDatrix has accumulated over two decades of experience conducting clinical trials across all phases (I–III). Our staff expertise spans a wide range of urological diseases, including prostate cancer, bladder cancer, kidney disease, kidney transplants, renal disease, and benign prostatic hyperplasia (BPH), making ClinDatrix an ideal partner for urology research.
Our team is adept at managing complex study protocols, designing specialized electronic data capture (EDC) systems, and ensuring smooth trial logistics. With a proven track record in urology, we offer sponsors the resources and expertise necessary for successful trial execution.
Key Highlights of ClinDatrix Urology Research Expertise
- Agility in Study Management: We deploy study databases on our secure servers within 5 weeks—significantly faster than the industry standard of 12 weeks—and implement protocol adjustments within 1–2 days, enabling quick responses to evolving study requirements.
- Regulatory and Compliance Excellence: ClinDatrix adheres to the highest regulatory standards, ensuring full compliance with ethical and legal requirements providing sponsors with confidence in every phase of their urology trials.
- Precision and Operational Excellence: From protocol development to data analysis, we deliver comprehensive support, ensuring that sponsors can efficiently and precisely achieve their study goals.
Partner with ClinDatrix to advance your urology research. Supported by a team of experts and operational excellence, we are committed to helping you meet your clinical trial objectives.
Contact us today to learn more!
ClinDatrix Urology Studies:
Service Codes
- BI = Biostatistics
- CL = Clinical
- DM = Data Management
- FS = Full Service
- MS = Medical Safety
- MW = Medical Writing
- RA = Regulatory Affairs
| Phase | Indication | Services | Sites | Patients |
|---|---|---|---|---|
| 2 | Renal Transplant Recipients | CL | 6 | 200 |